£520.00

The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in the United States

Price data last checked 78 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 13 days • 13 data points (No recent data available)

Historical
Generating forecast...
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 26 January 2026 29 January 2026 01 February 2026 04 February 2026 07 February 2026

Price Distribution

Price distribution over 13 days • 1 price levels

Days at Price
13 days 0 3 7 10 13 £520 Days at Price

Price Analysis

Most common price: £520 (13 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 13 days

Product Specifications
Format
Paperback
ASIN
B0BLR3KRYR
Category
Books > Subjects
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
10 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in India
98% match

The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in India

£515.00 28 Jan 2026
The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in the United States
97% match

The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in the United States

£520.00 06 Feb 2026
The 2023-2028 Outlook for Anticoagulant Drugs in the United States
97% match

The 2023-2028 Outlook for Anticoagulant Drugs in the United States

£520.00 01 Feb 2026
The 2023-2028 Outlook for Anticoagulant Reversal Drugs in the United States
97% match

The 2023-2028 Outlook for Anticoagulant Reversal Drugs in the United States

£520.00 01 Feb 2026
The 2023-2028 Outlook for Cholestrol Lowering Drugs in the United States
97% match

The 2023-2028 Outlook for Cholestrol Lowering Drugs in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Cardiac Rhythm Management Devices in the United States
97% match

The 2023-2028 Outlook for Cardiac Rhythm Management Devices in the United States

£520.00 07 Jan 2026
The 2023-2028 Outlook for Antiviral Drugs in the United States
96% match

The 2023-2028 Outlook for Antiviral Drugs in the United States

£520.00 30 Jan 2026
The 2023-2028 Outlook for Over the Counter Drugs in the United States
96% match

The 2023-2028 Outlook for Over the Counter Drugs in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Anticoagulants in the United States
96% match

The 2023-2028 Outlook for Anticoagulants in the United States

£520.00 01 Feb 2026
The 2023-2028 Outlook for OTC Drugs in the United States
96% match

The 2023-2028 Outlook for OTC Drugs in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in the United States
96% match

The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in the United States

£520.00 06 Feb 2026
The 2023-2028 Outlook for Electrocardiogram in the United States
96% match

The 2023-2028 Outlook for Electrocardiogram in the United States

£520.00 13 Jan 2026
The 2023-2028 Outlook for Anti-Malarial Drugs in the United States
96% match

The 2023-2028 Outlook for Anti-Malarial Drugs in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Statins in the United States
96% match

The 2023-2028 Outlook for Statins in the United States

£520.00 26 Jan 2026
The 2023-2028 Outlook for Kidney Cancer Drugs in the United States
96% match

The 2023-2028 Outlook for Kidney Cancer Drugs in the United States

£520.00 13 Jan 2026
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
96% match

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States

£520.00 14 Jan 2026
The 2023-2028 World Outlook for Cardiovascular Information Systems
96% match

The 2023-2028 World Outlook for Cardiovascular Information Systems

£795.00 12 Jan 2026
The 2023-2028 Outlook for End Stage Renal Diseases in the United States
96% match

The 2023-2028 Outlook for End Stage Renal Diseases in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Erythropoietin Drugs in the United States
96% match

The 2023-2028 Outlook for Erythropoietin Drugs in the United States

£520.00 06 Feb 2026
The 2023-2028 Outlook for Nocturia Drugs in the United States
96% match

The 2023-2028 Outlook for Nocturia Drugs in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Anti-Inflammatory Asthma Drugs in the United States
96% match

The 2023-2028 Outlook for Anti-Inflammatory Asthma Drugs in the United States

£520.00 06 Feb 2026
The 2023-2028 Outlook for Anti-Inflammatory Lupus Drugs in the United States
96% match

The 2023-2028 Outlook for Anti-Inflammatory Lupus Drugs in the United States

£520.00 28 Jan 2026
The 2023-2028 Outlook for Contraceptive Drugs in the US
96% match

The 2023-2028 Outlook for Contraceptive Drugs in the US

£520.00 25 Feb 2026
The 2023-2028 Outlook for Diabetes Drugs in the United States
96% match

The 2023-2028 Outlook for Diabetes Drugs in the United States

£520.00 10 Dec 2025